REPH - Recro Pharma, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - REPH (1588972)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
45 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P9+3+11+6+10
S20+3+7+8+32

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2018-01-04
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$8.84-1,579726,0550%-$13,956
2018-01-04
REPHScp Vitalife Partners II LP10%S - Sale$8.84-4,7322,172,9000%-$41,822
M
2018-01-02
REPHScp Vitalife Partners II LP10%S - Sale$8.88-38,8102,177,632-2%-$344,688
M
2018-01-02
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$8.88-12,964727,634-2%-$115,139
M
2017-12-28
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$9.27-6,090740,598-1%-$56,481
M
2017-12-28
REPHScp Vitalife Partners II LP10%S - Sale$9.27-18,2312,216,442-1%-$169,080
M
2017-12-26
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$9.56-4,405746,688-1%-$42,101
M
2017-12-26
REPHScp Vitalife Partners II LP10%S - Sale$9.56-13,1892,234,673-1%-$126,056
M
2017-12-20
REPHBroadfin Healthcare Master Fund Ltd10%S - Sale$9.87-76,0002,436,025-3%-$750,240
M
2017-12-12
REPHBroadfin Healthcare Master Fund Ltd10%S - Sale$9.86-93,2372,512,025-4%-$919,128
2017-12-05
REPHBroadfin Healthcare Master Fund Ltd10%S - Sale$10.00-100,0002,605,262-4%-$1,000,000
M
2017-11-28
REPHBroadfin Healthcare Master Fund Ltd10%S - Sale$9.58-222,6162,705,262-8%-$2,133,063
M
2017-11-21
REPHBroadfin Healthcare Master Fund Ltd10%S - Sale$9.45-172,2082,927,878-6%-$1,626,565
M
2017-06-12
REPHFlynn James EPossible Member of 10% Group, 10%S - Sale$6.39-110,4471,901,685-5%-$706,226
M
2017-06-07
REPHFlynn James EPossible Member of 10% Group, 10%S - Sale$7.06-62,8682,012,132-3%-$444,010
2017-05-12
REPHStonepine Capital Management, LLC10%S - Sale$7.40-510,0001,902,380-21%-$3,774,204
M
2017-05-09
REPHStonepine Capital Management, LLC10%S - Sale$7.65-244,6292,412,380-9%-$1,871,765+4
M
2017-05-03
REPHStonepine Capital Management, LLC10%S - Sale$7.70-217,3082,657,009-8%-$1,672,9610+2
A
2017-02-17
REPHScp Vitalife Partners II LP10%S - Sale$7.59-9,9832,292,8390%-$75,791-1-1-1
AM
2017-03-14
REPHScp Vitalife Partners II LP10%S - Sale$8.00-44,9772,247,862-2%-$359,992-1-1-1
AM
2017-02-14
REPHScp Vitalife Partners II LP10%S - Sale$7.89-12,0652,302,822-1%-$95,171-1-1-1
M
2017-03-14
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$8.00-15,023751,093-2%-$120,243+1-5+3
M
2017-03-14
REPHScp Vitalife Partners II LP10%S - Sale$8.00-44,9772,247,922-2%-$359,992+1-5+3
2017-02-17
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$7.59-3,334766,1160%-$25,312-4+2-1
2017-02-17
REPHScp Vitalife Partners II LP10%S - Sale$7.59-9,9832,292,8990%-$75,791-4+2-1
M
2017-02-14
REPHScp Vitalife Partners II LP10%S - Sale$7.89-12,0652,302,882-1%-$95,171-1-6+2
M
2017-02-14
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$7.89-4,030769,450-1%-$31,789-1-6+2
2017-02-13
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$7.97-2,651773,4800%-$21,130-1-6+1
2017-02-13
REPHScp Vitalife Partners II LP10%S - Sale$7.97-7,9372,314,8870%-$63,261-1-6+1
M
2016-12-15
REPHWeisman WayneDirP - Purchase$6.55+7,0007,000New+$45,830+5+40
2016-12-16
REPHFlynn KarenDirP - Purchase$6.71+800800New+$5,364+5+40
2016-12-15
REPHAltomari AlfredDirP - Purchase$6.55+1,5001,500New+$9,825+4+17+7
2016-12-13
REPHBroadfin Healthcare Master Fund Ltd10%P - Purchase$6.00+650,0003,100,086+27%+$3,900,000+1+10+10
2016-08-16
REPHBroadfin Healthcare Master Fund Ltd10%P - Purchase$7.50+390,0002,450,086+19%+$2,925,000-1+14+8-8
2016-05-31
REPHGraff FredChief Commercial OfficerP - Purchase$8.46+8,0008,000New+$67,7070+1-6+3
M
2016-05-26
REPHMcCallum StewartChief Medical OfficerP - Purchase$8.22+1,2501,250New+$10,275+4+5-1-4
2016-05-23
REPHScp Vitalife Partners II LP10%S - Sale$6.30-7,4972,322,8240%-$47,232+10+18+13+21
2016-05-23
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$6.30-2,503776,1310%-$15,769+10+18+13+21
2016-05-23
REPHMack RandallSVP, DevelopmentP - Purchase$6.30+2,0002,000New+$12,600+10+18+13+21
M
2015-11-23
REPHWeisman WayneDirS - Sale$7.91-58,3315,458,016-1%-$461,392+10+27+24+37
M
2015-11-23
REPHLudomirski AbrahamDirS - Sale$7.91-58,3315,458,016-1%-$461,392+10+27+24+37
M
2015-11-23
REPHChurchill Winston JDirS - Sale$7.91-58,3315,458,016-1%-$461,392+10+27+24+37
M
2016-05-19
REPHScp Vitalife Partners II LP10%S - Sale$6.46-18,7402,330,321-1%-$120,967+10+27+24+37
M
2016-05-19
REPHScp Vitalife Partners (Israel) Ii, L.P.10%S - Sale$6.46-6,260778,634-1%-$40,408+10+27+24+37
2016-05-19
REPHNichols DonnaCAO, ControllerP - Purchase$6.48+1,1402,340+95%+$7,387+1+28+25+38

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top